Article metrics
PDF
Other content recommended for you
- CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD
- Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders
- Antibodies to MOG and AQP4 in children with neuromyelitis optica and limited forms of the disease
- CSF high-mobility group box 1 is associated with intrathecal inflammation and astrocytic damage in neuromyelitis optica
- Early predictors of disability of paediatric-onset AQP4-IgG-seropositive neuromyelitis optica spectrum disorders
- Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis
- Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies
- Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations
- Neuromyelitis optica spectrum disorder as a paraneoplastic syndrome: a rare and challenging diagnosis
- Overlapping CNS inflammatory diseases: differentiating features of NMO and MS